Does LEBRIKIZUMAB-LBKZ Cause Dermatitis atopic? 32 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Dermatitis atopic have been filed in association with LEBRIKIZUMAB-LBKZ. This represents 4.4% of all adverse event reports for LEBRIKIZUMAB-LBKZ.
32
Reports of Dermatitis atopic with LEBRIKIZUMAB-LBKZ
4.4%
of all LEBRIKIZUMAB-LBKZ reports
0
Deaths
3
Hospitalizations
How Dangerous Is Dermatitis atopic From LEBRIKIZUMAB-LBKZ?
Of the 32 reports, 3 (9.4%) required hospitalization.
Is Dermatitis atopic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEBRIKIZUMAB-LBKZ. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does LEBRIKIZUMAB-LBKZ Cause?
Injection site pain (89)
Conjunctivitis (51)
Rash (50)
Pruritus (47)
Eczema (39)
Drug ineffective (36)
Erythema (34)
Urticaria (25)
Hypersensitivity (23)
Underdose (22)
What Other Drugs Cause Dermatitis atopic?
DUPILUMAB (33,670)
TRALOKINUMAB-LDRM (613)
UPADACITINIB (525)
RUXOLITINIB (211)
TACROLIMUS (200)
CRISABOROLE (134)
NEMOLIZUMAB-ILTO (117)
OMALIZUMAB (111)
ABROCITINIB (110)
PREDNISONE (105)
Which LEBRIKIZUMAB-LBKZ Alternatives Have Lower Dermatitis atopic Risk?
LEBRIKIZUMAB-LBKZ vs LECANEMAB
LEBRIKIZUMAB-LBKZ vs LECANEMAB-IRMB
LEBRIKIZUMAB-LBKZ vs LECITHIN\POLOXAMER 407
LEBRIKIZUMAB-LBKZ vs LEDIPASVIR
LEBRIKIZUMAB-LBKZ vs LEDIPASVIR\SOFOSBUVIR